Tag Archives: China’s Sinovac secures $515 million funding to boost COVID-19 vaccine production

SHANGHAI: China’s Sinovac Biotech has secured $515 million in funding from a local firm to double production capacity of its coronavirus vaccine, the companies said on Monday, as it expects efficacy data of its experimental shot this month. The investment deal also comes as Sinovac expands supply deals and trials of its experimental COVID-19 vaccine CoronaVac with more countries following …

Read More »